{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T04:31:16Z","timestamp":1778646676478,"version":"3.51.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Updates Surg"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s13304-019-00626-3","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T09:33:23Z","timestamp":1552124003000},"page":"57-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Dissecting the multinodular hepatocellular carcinoma subset: is there a survival benefit after hepatectomy?"],"prefix":"10.1007","volume":"71","author":[{"given":"Matteo","family":"Donadon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Procopio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Del Fabbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Cimino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Vigan\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Palmisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guido","family":"Torzilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"issue":"Suppl 4","key":"626_CR1","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1634\/theoncologist.2010-S4-05","volume":"15","author":"AP Venook","year":"2010","unstructured":"Venook AP, Papandreou C, Furuse J et al (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5\u201313","journal-title":"Oncologist"},{"key":"626_CR2","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R et al (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10:35\u201343","journal-title":"Lancet Oncol"},{"key":"626_CR3","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association for the Study of the Liver","year":"2012","unstructured":"European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer (2012) EASL-EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma. J Hepatol 56:908\u2013943","journal-title":"J Hepatol"},{"key":"626_CR4","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1097\/SLA.0b013e31828329b8","volume":"257","author":"G Torzilli","year":"2013","unstructured":"Torzilli G, Belghiti J, Kokudo N et al (2013) A snapshot of the effective indications and results of surgery for hepatocellular carcinoma in tertiary referral centers: is it adherent to the EASL\/AASLD recommendations?: an observational study of the HCC East-West study group. Ann Surg 257:929\u2013937","journal-title":"Ann Surg"},{"key":"626_CR5","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1002\/hep.27745","volume":"62","author":"S Roayaie","year":"2015","unstructured":"Roayaie S, Jibara G, Tabrizian P et al (2015) The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology 62:440\u2013451","journal-title":"Hepatology"},{"key":"626_CR6","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.ejso.2015.05.023","volume":"41","author":"R Ciria","year":"2015","unstructured":"Ciria R, Lopez-Cillero P, Gallardo AB et al (2015) Optimizing the management of patients with BCLC stage-B hepatocellular carcinoma: modern surgical resection as a feasible alternative to transarterial chemoemolization. Eur J Surg Oncol 41:1153\u20131161","journal-title":"Eur J Surg Oncol"},{"key":"626_CR7","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s11605-016-3132-0","volume":"20","author":"G Torzilli","year":"2016","unstructured":"Torzilli G, Donadon M, Belghiti J et al (2016) Predicting individual survival after hepatectomy for hepatocellular carcinoma: a novel nomogram from the \u201cHCC East & West Study Group\u201d. J Gastrointest Surg 20:1154\u20131162","journal-title":"J Gastrointest Surg"},{"key":"626_CR8","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S1365-182X(17)30755-4","volume":"2","author":"J Belghiti","year":"2000","unstructured":"Belghiti J, Clavien P, Gadzijev E (2000) The Brisbane 2000 terminology of liver anatomy and resections. HPB (Oxford) 2:333\u2013339","journal-title":"HPB (Oxford)"},{"key":"626_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien P-A (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"626_CR10","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00268-014-2786-6","volume":"39","author":"M Donadon","year":"2014","unstructured":"Donadon M, Costa G, Cimino M et al (2014) Safe hepatectomy selection criteria for hepatocellular carcinoma patients: a validation of 336 consecutive hepatectomies. The BILCHE score. World J Surg 39:237\u2013243","journal-title":"World J Surg"},{"key":"626_CR11","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/bjs.1800600817","volume":"60","author":"RNH Pugh","year":"1973","unstructured":"Pugh RNH, Murray-Lyon IM, Dawson JL et al (1973) Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 60:646\u2013649","journal-title":"Br J Surg"},{"key":"626_CR12","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1001\/archsurg.143.11.1082","volume":"143","author":"G Torzilli","year":"2008","unstructured":"Torzilli G, Donadon M, Marconi M et al (2008) Hepatectomy for stage b and stage c hepatocellular carcinoma in the barcelona clinic liver cancer classification: results of a prospective analysis. Arch Surg 143:1082\u20131090","journal-title":"Arch Surg"},{"key":"626_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/BF01655244","volume":"10","author":"H Kinoshita","year":"1986","unstructured":"Kinoshita H, Sakai K, Hirohashi K et al (1986) Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg 10:803\u2013808","journal-title":"World J Surg"},{"key":"626_CR14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.jamcollsurg.2005.04.026","volume":"201","author":"G Torzilli","year":"2005","unstructured":"Torzilli G, Montorsi M, Donadon M et al (2005) \u201cRadical but conservative\u201d is the main goal for ultrasonography-guided liver resection: prospective validation of this approach. J Am Coll Surg 201:517\u2013528","journal-title":"J Am Coll Surg"},{"key":"626_CR15","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1097\/SLA.0b013e3181b7fdcd","volume":"251","author":"G Torzilli","year":"2010","unstructured":"Torzilli G, Procopio F, Cimino M et al (2010) Anatomical segmental and subsegmental resection of the liver for hepatocellular carcinoma: a new approach by means of ultrasound-guided vessel compression. Ann Surg 251:229\u2013235","journal-title":"Ann Surg"},{"key":"626_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/978-88-470-5510-0","volume-title":"Ultrasound-guided liver surgery: an atlas","author":"G Torzilli","year":"2014","unstructured":"Torzilli G (2014) Ultrasound-guided liver surgery: an atlas. Springer, Berlin"},{"key":"626_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s00268-015-3143-0","volume":"40","author":"M Donadon","year":"2016","unstructured":"Donadon M, Costa G, Cimino M et al (2016) Diagnosis and management of bile leaks after hepatectomy: results of a prospective analysis of 475 hepatectomies. World J Surg 40:172\u2013181","journal-title":"World J Surg"},{"key":"626_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jclinepi.2008.02.011","volume":"62","author":"RH Groenwold","year":"2009","unstructured":"Groenwold RH, Hak E, Hoes AW (2009) Quantitative assessment of unobserved confounding is mandatory in nonrandomized intervention studies. J Clin Epidemiol 62:22\u201328","journal-title":"J Clin Epidemiol"},{"key":"626_CR19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.2517-6161.1983.tb01258.x","volume":"45","author":"JB Copas","year":"1983","unstructured":"Copas JB (1983) Regression, prediction and shrinkage. J R Stat Soc 45:311\u2013354","journal-title":"J R Stat Soc"},{"key":"626_CR20","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","volume":"48","author":"P Peduzzi","year":"1995","unstructured":"Peduzzi P, Concato J, Feinstein AR et al (1995) Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503\u20131510","journal-title":"J Clin Epidemiol"},{"key":"626_CR21","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1053\/he.2000.5852","volume":"31","author":"M Malinchoc","year":"2000","unstructured":"Malinchoc M, Kamath PS, Gordon FD et al (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864\u2013871","journal-title":"Hepatology"},{"key":"626_CR22","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jhep.2014.03.012","volume":"61","author":"L Yin","year":"2014","unstructured":"Yin L, Li H, Li AJ et al (2014) Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan Criteria: a RCT. J Hepatol 61:82\u201388","journal-title":"J Hepatol"},{"key":"626_CR23","doi-asserted-by":"publisher","first-page":"e68193","DOI":"10.1371\/journal.pone.0068193","volume":"8","author":"JH Zhong","year":"2013","unstructured":"Zhong JH, Xiang BD, Gong WF et al (2013) Comparison of long-term survival of patients with BCLC stage B hepatocellular carcinoma after liver resection or transarterial chemoembolization. PLoS One 8:e68193","journal-title":"PLoS One"},{"key":"626_CR24","doi-asserted-by":"publisher","first-page":"366","DOI":"10.3748\/wjg.v19.i3.366","volume":"19","author":"SH Choi","year":"2013","unstructured":"Choi SH, Choi GH, Kim SU et al (2013) Role of surgical resection for multiple hepatocellular carcinomas. World J Gastroenterol 19:366\u2013374","journal-title":"World J Gastroenterol"},{"key":"626_CR25","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1111\/liv.12649","volume":"35","author":"F Farinati","year":"2015","unstructured":"Farinati F, Vanin V, Giacomin A et al (2015) BCLC stage B hepatocellular carcinoma and transcatheter arterial chemoembolization: a 20-year survey by the Italian Liver Cancer group. Liver Int 35:223\u2013231","journal-title":"Liver Int"},{"key":"626_CR26","doi-asserted-by":"publisher","first-page":"5541","DOI":"10.7314\/APJCP.2015.16.13.5541","volume":"16","author":"XD Yang","year":"2015","unstructured":"Yang XD, Pan LH, Wang L et al (2015) Systematic review of single large and\/or multinodular hepatocellular carcinoma: surgical resection improves survival. Asian Pac J Cancer Prev 16:5541\u20135547","journal-title":"Asian Pac J Cancer Prev"},{"key":"626_CR27","doi-asserted-by":"crossref","first-page":"18715","DOI":"10.18632\/oncotarget.4134","volume":"6","author":"X Qi","year":"2015","unstructured":"Qi X, Wang D, Su C et al (2015) Hepatic resection versus transarterial chemoembolization for the initial treatment of hepatocellular carcinoma: a systematic review and meta-analysis. Oncotarget 6:18715\u201318733","journal-title":"Oncotarget"},{"key":"626_CR28","doi-asserted-by":"publisher","first-page":"696120","DOI":"10.1155\/2015\/696120","volume":"2015","author":"T Kapitanov","year":"2015","unstructured":"Kapitanov T, Neumann UP, Schmeding M (2015) Hepatocellular carcinoma in liver cirrhosis: surgical resection versus transarterial chemoembolization\u2014a meta-analysis. Gastroenterol Res Pract 2015:696120","journal-title":"Gastroenterol Res Pract"},{"key":"626_CR29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.jhep.2014.10.037","volume":"62","author":"A Vitale","year":"2015","unstructured":"Vitale A, Burra P, Frigo AC et al (2015) Survival benefit of liver resection for patients with hepatocellular carcinoma across different Barcelona clinic liver cancer stages: a multicentre study. J Hepatol 62:617\u2013624","journal-title":"J Hepatol"},{"key":"626_CR30","doi-asserted-by":"publisher","first-page":"e180","DOI":"10.1097\/MD.0000000000000180","volume":"93","author":"L Jianyong","year":"2014","unstructured":"Jianyong L, Lunan Y, Wentao W et al (2014) Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Medicine (Baltimore) 93:e180","journal-title":"Medicine (Baltimore)"},{"key":"626_CR31","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1053\/jhep.2002.33156","volume":"35","author":"CM Lo","year":"2002","unstructured":"Lo CM, Ngan H, Tso WK et al (2002) Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology 35:1164\u20131171","journal-title":"Hepatology"},{"key":"626_CR32","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1016\/S0140-6736(02)08649-X","volume":"359","author":"JM Llovet","year":"2002","unstructured":"Llovet JM, Real MI, Montana X et al (2002) Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet 359:1734\u20131739","journal-title":"Lancet"},{"key":"626_CR33","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1053\/jhep.2003.50047","volume":"37","author":"JM Llovet","year":"2003","unstructured":"Llovet JM, Bruix J (2003) Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival. Hepatology 37:429\u2013442","journal-title":"Hepatology"},{"key":"626_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00270-006-0062-3","volume":"30","author":"L Marelli","year":"2007","unstructured":"Marelli L, Stigliano R, Triantos C et al (2007) Transarterial therapy for hepatocellular carcinoma: which technique is more effective? A systematic review of cohort and randomized studies. Cardiovasc Intervent Radiol 30:6\u201325","journal-title":"Cardiovasc Intervent Radiol"},{"key":"626_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1148\/radiol.2241011262","volume":"224","author":"C Camma","year":"2002","unstructured":"Camma C, Schepis F, Orlando A et al (2002) Transarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trials. Radiology 224:47\u201354","journal-title":"Radiology"},{"key":"626_CR36","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1001\/archsurg.134.9.984","volume":"134","author":"G Torzilli","year":"1999","unstructured":"Torzilli G, Makuuchi M, Inoue K et al (1999) No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach. Arch Surg 134:984\u2013992","journal-title":"Arch Surg"},{"key":"626_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1245\/ASO.2005.06.004","volume":"12","author":"KK Ng","year":"2005","unstructured":"Ng KK, Vauthey JN, Pawlik TM et al (2005) Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol 12:364\u2013373","journal-title":"Ann Surg Oncol"},{"key":"626_CR38","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/hep.24451","volume":"54","author":"B Sangro","year":"2011","unstructured":"Sangro B, Carpanese L, Cianni R et al (2011) Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. Hepatology 54:868\u2013878","journal-title":"Hepatology"},{"key":"626_CR39","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/hep.26014","volume":"57","author":"V Mazzaferro","year":"2013","unstructured":"Mazzaferro V, Sposito C, Bhoori S et al (2013) Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study. Hepatology 57:1826\u20131837","journal-title":"Hepatology"},{"key":"626_CR40","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1002\/bjs.10613","volume":"104","author":"A Cucchetti","year":"2017","unstructured":"Cucchetti A, Mazzaferro V, Pinna AD et al (2017) Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma. Br J Surg 104:1704\u20131712","journal-title":"Br J Surg"},{"key":"626_CR41","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jamcollsurg.2012.04.013","volume":"215","author":"F Giuliante","year":"2012","unstructured":"Giuliante F, Ardito F, Pinna AD et al (2012) Liver resection for hepatocellular carcinoma\u2009\u2264\u20093\u00a0cm: results of an Italian Multicenter Study on 588 patients. J Am Coll Surg 215:244\u2013254","journal-title":"J Am Coll Surg"},{"key":"626_CR42","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/S1470-2045(15)00198-9","volume":"16","author":"J Bruix","year":"2015","unstructured":"Bruix J, Takayama T, Mazzaferro V et al (2015) Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial. Lancet Oncol 16:1344\u20131354","journal-title":"Lancet Oncol"},{"key":"626_CR43","first-page":"348","volume":"32","author":"L Bolondi","year":"2012","unstructured":"Bolondi L, Burroughs A, Dufour JF et al (2012) Heterogeneity of patients with intermediate (BCLC B) hepatocellular carcinoma: proposal for a subclassification to facilitate treatment decisions. Semin Liver Dis 32:348\u2013359","journal-title":"Semin Liver Dis"},{"key":"626_CR44","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/liv.12696","volume":"35","author":"A Weinmann","year":"2015","unstructured":"Weinmann A, Koch S, Sprinzl M et al (2015) Survival analysis of proposed BCLC-B subgroups in hepatocellular carcinoma patients. Liver Int 35:591\u2013600","journal-title":"Liver Int"}],"container-title":["Updates in Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-019-00626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13304-019-00626-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13304-019-00626-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T17:16:42Z","timestamp":1721063802000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13304-019-00626-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["626"],"URL":"https:\/\/doi.org\/10.1007\/s13304-019-00626-3","relation":{},"ISSN":["2038-131X","2038-3312"],"issn-type":[{"value":"2038-131X","type":"print"},{"value":"2038-3312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"16 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was conducted according with the Helsinki declaration about ethical standards. Moreover, it was approved by the local ethical committee of our institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained by each patient included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}